Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
11.78
Dollar change
+0.46
Percentage change
4.06
%
IndexRUT P/E- EPS (ttm)-8.40 Insider Own17.78% Shs Outstand60.04M Perf Week0.68%
Market Cap708.92M Forward P/E- EPS next Y-5.04 Insider Trans0.00% Shs Float49.48M Perf Month-13.25%
Income-503.14M PEG- EPS next Q-1.66 Inst Own98.47% Short Float17.09% Perf Quarter-47.95%
Sales91.06M P/S7.79 EPS this Y28.60% Inst Trans0.73% Short Ratio7.87 Perf Half Y-39.37%
Book/sh11.73 P/B1.00 EPS next Y22.02% ROA-50.61% Short Interest8.46M Perf Year-77.19%
Cash/sh11.94 P/C0.99 EPS next 5Y16.80% ROE-54.72% 52W Range10.92 - 59.99 Perf YTD-45.64%
Dividend Est.- P/FCF- EPS past 5Y-2.28% ROI-71.29% 52W High-80.36% Beta0.92
Dividend TTM- Quick Ratio12.22 Sales past 5Y3395.58% Gross Margin96.12% 52W Low7.88% ATR (14)0.83
Dividend Ex-Date- Current Ratio12.22 EPS Y/Y TTM10.43% Oper. Margin-557.93% RSI (14)39.25 Volatility7.21% 6.10%
Employees487 Debt/Eq0.00 Sales Y/Y TTM868.87% Profit Margin-552.52% Recom2.67 Target Price22.24
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q26.68% Payout- Rel Volume0.72 Prev Close11.32
Sales Surprise50.21% EPS Surprise-9.16% Sales Q/Q139.89% EarningsApr 25 BMO Avg Volume1.07M Price11.78
SMA20-6.22% SMA50-21.86% SMA200-40.43% Trades Volume770,833 Change4.06%
Date Action Analyst Rating Change Price Target Change
Apr-17-24Downgrade BofA Securities Neutral → Underperform $24 → $14
Dec-12-23Initiated Deutsche Bank Hold $21
Aug-08-23Downgrade Needham Buy → Hold
Aug-08-23Downgrade Goldman Buy → Neutral $22
Aug-08-23Downgrade Canaccord Genuity Buy → Hold $64 → $21
Aug-07-23Downgrade Wedbush Outperform → Neutral $51 → $22
Aug-07-23Downgrade Stifel Buy → Hold $60 → $22
Aug-07-23Downgrade RBC Capital Mkts Outperform → Sector Perform $71 → $25
Aug-07-23Downgrade Oppenheimer Outperform → Perform
Aug-07-23Downgrade BofA Securities Buy → Neutral $66 → $25
May-13-24 07:57PM
May-07-24 06:30AM
Apr-30-24 12:57PM
Apr-26-24 11:27AM
Apr-25-24 02:33PM
10:54AM Loading…
10:54AM
08:04AM
07:35AM
06:30AM
Apr-18-24 11:37AM
10:01AM
Apr-17-24 04:10PM
02:41PM
08:46AM
07:44AM
06:39AM Loading…
06:39AM
06:30AM
Apr-11-24 07:29PM
06:30AM
Apr-10-24 06:09PM
07:47AM
Mar-18-24 10:16AM
Mar-15-24 11:30AM
Feb-28-24 06:30AM
Feb-15-24 01:36PM
10:50AM
Feb-14-24 07:15AM
06:42AM
06:30AM
Feb-07-24 10:00AM
06:30AM Loading…
Jan-31-24 06:30AM
Jan-08-24 06:32AM
06:30AM
Jan-02-24 06:30AM
Dec-20-23 02:15PM
Dec-14-23 06:30AM
Dec-07-23 11:31AM
Nov-13-23 11:13AM
Nov-08-23 01:11PM
07:59AM
06:30AM
Nov-07-23 06:02PM
05:41PM
12:40PM
08:44AM
07:40AM
07:21AM
06:30AM
06:30AM
Nov-02-23 10:00AM
Oct-31-23 10:01AM
Oct-24-23 06:42AM
06:30AM
Oct-19-23 12:16PM
Oct-18-23 06:30AM
Oct-14-23 01:14PM
Sep-15-23 03:01PM
Sep-13-23 04:43PM
Sep-06-23 02:27PM
06:30AM
Sep-01-23 03:51PM
01:27PM
Aug-31-23 11:10AM
10:10AM
09:36AM
07:00AM
06:44AM
06:40AM
06:30AM
Aug-24-23 10:23AM
05:10AM
Aug-11-23 12:05PM
11:23AM
10:34AM
08:50AM
Aug-08-23 09:42AM
09:00AM
06:02AM
Aug-07-23 04:06PM
03:50PM
11:58AM
11:44AM
10:32AM
10:32AM
10:14AM
10:04AM
09:57AM
09:57AM
08:09AM
08:06AM
07:40AM
06:30AM
Aug-04-23 10:45PM
10:42PM
08:44PM
08:13PM
07:24PM
07:13PM
07:11PM
Jul-29-23 11:39AM
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
IGUCHI KIMICFO & TreasurerJan 02 '24Option Exercise1.361,6422,23370,429Jan 04 04:07 PM
Barrett ElizabethDirectorAug 09 '23Buy18.642,00037,2793,000Aug 11 08:51 AM